News against the fight of human papillomavirus-induced cancers with the preventive vaccine.

Gardasil 9 (HPV 9-valent Vaccine, Recombinant), a vaccine for the prevention of HPV, has been approved by the FDA for use in males and females aged 9 through 45 years.

Gardasil 9 was previously approved by the FDA in 2014 for use in males and females aged 9 through 26 years. The vaccine has been shown to prevent cancers and other diseases caused by the 9 types of HPV: 6, 11, 16, 18, 31, 33, 45, 52, and 58.